Macroaxis considers BioTime unknown risk given 2 months investment horizon. BioTime secures Sharpe Ratio (or Efficiency) of 0.108 which signifies that the organization had 0.108% of return per unit of risk over the last 2 months. Our philosophy towards foreseeing volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. By analyzing BioTime technical indicators you can presently evaluate if the expected return of 0.6442% is justified by implied risk. Please makes use of BioTime Risk Adjusted Performance of 0.0836, Mean Deviation of 5.05 and Downside Deviation of 5.73 to double-check if our risk estimates are consistent with your expectations.
60 Days Market Risk
Chance of Distress in 24 months
60 Days Economic Sensitivity
|Horizon||30 Days Login to change|
BioTime Market Sensitivity
|As returns on market increase, returns on owning BioTime are expected to decrease at a much smaller rate. During bear market, BioTime is likely to outperform the market. 2 Months Beta |Analyze BioTime Demand TrendCheck current 30 days BioTime correlation with market (DOW)|
β = -0.0676
BioTime Central Daily Price Deviation
BioTime Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
BioTime Projected Return Density Against MarketAssuming 30 trading days horizon, BioTime has beta of -0.0676 . This suggests as returns on benchmark increase, returns on holding BioTime are expected to decrease at a much smaller rate. During bear market, however, BioTime is likely to outperform the market. In addition to that, The company has an alpha of 1.128 implying that it can potentially generate 1.128% excess return over DOW after adjusting for the inherited market risk (beta).
Predicted Return Density
Assuming 30 trading days horizon, the coefficient of variation of BioTime is 926.11. The daily returns are destributed with a variance of 35.6 and standard deviation of 5.97. The mean deviation of BioTime is currently at 3.12. For similar time horizon, the selected benchmark (DOW) has volatility of 0.64
|Alpha over DOW||=||1.13|
|Beta against DOW||=||0.07|
BioTime Return Volatilitythe company assumes 5.9664% volatility of returns over the 30 days investment horizon. the entity inherits 0.5829% risk (volatility on return distribution) over the 30 days horizon.
BioTime Investment Opportunity
BioTime has a volatility of 5.97 and is 10.29 times more volatile than DOW. 53% of all equities and portfolios are less risky than BioTime. Compared to the overall equity markets, volatility of historical daily returns of BioTime is higher than 53 (%) of all global equities and portfolios over the last 30 days.
BioTime Current Risk Indicators
|Risk Adjusted Performance||0.0836|
|Market Risk Adjusted Performance||(16.56)|
|Coefficient Of Variation||859.49|
BioTime Suggested Diversification Pairs
|Twitter vs. BioTime|
|Alphabet vs. BioTime|
|Salesforce vs. BioTime|
|Vanguard REIT vs. BioTime|
|Sprint vs. BioTime|
|Microsoft vs. BioTime|
|Facebook vs. BioTime|
|Ford Motor vs. BioTime|
|Visa vs. BioTime|